| pubmed-article:11134203 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11134203 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:11134203 | lifeskim:mentions | umls-concept:C0684249 | lld:lifeskim |
| pubmed-article:11134203 | lifeskim:mentions | umls-concept:C0033522 | lld:lifeskim |
| pubmed-article:11134203 | lifeskim:mentions | umls-concept:C0872169 | lld:lifeskim |
| pubmed-article:11134203 | lifeskim:mentions | umls-concept:C0205210 | lld:lifeskim |
| pubmed-article:11134203 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:11134203 | pubmed:dateCreated | 2001-1-26 | lld:pubmed |
| pubmed-article:11134203 | pubmed:abstractText | To prospectively study the impact of (18)F fluorodeoxyglucose (FDG) positron emission tomography (PET) on clinical management of patients with non-small-cell lung cancer (NSCLC). | lld:pubmed |
| pubmed-article:11134203 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11134203 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11134203 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11134203 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11134203 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11134203 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11134203 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:11134203 | pubmed:issn | 0732-183X | lld:pubmed |
| pubmed-article:11134203 | pubmed:author | pubmed-author:WardR DRD | lld:pubmed |
| pubmed-article:11134203 | pubmed:author | pubmed-author:HoggAA | lld:pubmed |
| pubmed-article:11134203 | pubmed:author | pubmed-author:BallD LDL | lld:pubmed |
| pubmed-article:11134203 | pubmed:author | pubmed-author:KalevGG | lld:pubmed |
| pubmed-article:11134203 | pubmed:author | pubmed-author:HicksR JRJ | lld:pubmed |
| pubmed-article:11134203 | pubmed:author | pubmed-author:MacManusM PMP | lld:pubmed |
| pubmed-article:11134203 | pubmed:author | pubmed-author:McKenzieA FAF | lld:pubmed |
| pubmed-article:11134203 | pubmed:author | pubmed-author:BinnsD SDS | lld:pubmed |
| pubmed-article:11134203 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11134203 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:11134203 | pubmed:volume | 19 | lld:pubmed |
| pubmed-article:11134203 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11134203 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11134203 | pubmed:pagination | 111-8 | lld:pubmed |
| pubmed-article:11134203 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:11134203 | pubmed:meshHeading | pubmed-meshheading:11134203... | lld:pubmed |
| pubmed-article:11134203 | pubmed:meshHeading | pubmed-meshheading:11134203... | lld:pubmed |
| pubmed-article:11134203 | pubmed:meshHeading | pubmed-meshheading:11134203... | lld:pubmed |
| pubmed-article:11134203 | pubmed:meshHeading | pubmed-meshheading:11134203... | lld:pubmed |
| pubmed-article:11134203 | pubmed:meshHeading | pubmed-meshheading:11134203... | lld:pubmed |
| pubmed-article:11134203 | pubmed:meshHeading | pubmed-meshheading:11134203... | lld:pubmed |
| pubmed-article:11134203 | pubmed:meshHeading | pubmed-meshheading:11134203... | lld:pubmed |
| pubmed-article:11134203 | pubmed:meshHeading | pubmed-meshheading:11134203... | lld:pubmed |
| pubmed-article:11134203 | pubmed:meshHeading | pubmed-meshheading:11134203... | lld:pubmed |
| pubmed-article:11134203 | pubmed:meshHeading | pubmed-meshheading:11134203... | lld:pubmed |
| pubmed-article:11134203 | pubmed:meshHeading | pubmed-meshheading:11134203... | lld:pubmed |
| pubmed-article:11134203 | pubmed:meshHeading | pubmed-meshheading:11134203... | lld:pubmed |
| pubmed-article:11134203 | pubmed:meshHeading | pubmed-meshheading:11134203... | lld:pubmed |
| pubmed-article:11134203 | pubmed:meshHeading | pubmed-meshheading:11134203... | lld:pubmed |
| pubmed-article:11134203 | pubmed:meshHeading | pubmed-meshheading:11134203... | lld:pubmed |
| pubmed-article:11134203 | pubmed:meshHeading | pubmed-meshheading:11134203... | lld:pubmed |
| pubmed-article:11134203 | pubmed:meshHeading | pubmed-meshheading:11134203... | lld:pubmed |
| pubmed-article:11134203 | pubmed:year | 2001 | lld:pubmed |
| pubmed-article:11134203 | pubmed:articleTitle | Clinical impact of (18)F fluorodeoxyglucose positron emission tomography in patients with non-small-cell lung cancer: a prospective study. | lld:pubmed |
| pubmed-article:11134203 | pubmed:affiliation | Department of Nuclear Medicine, Alfred Hospital, Prahran, Australia. | lld:pubmed |
| pubmed-article:11134203 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11134203 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11134203 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11134203 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11134203 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11134203 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11134203 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11134203 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11134203 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11134203 | lld:pubmed |
